Related Experiment Videos
Hypertension in the oncology setting.
1Rocky Mountain Cancer Center in Denver, CO, USA. katherine.albert@usoncology.com
Clinical Journal of Oncology Nursing
|December 31, 2005
Summary
Hypertension (HTN) is a frequent issue in cancer patients, often linked to treatments. Proper screening and medication selection, guided by established guidelines, are crucial for managing HTN in this population.
Area of Science:
- Oncology
- Cardiology
- Pharmacology
Background:
- Hypertension (HTN) is a common comorbidity in cancer patients.
- HTN can also arise as a complication of cancer therapies.
- Effective management of HTN is vital for patient outcomes.
Observation:
- Patient assessment involves reviewing medical history and current medications.
- Screening protocols are essential for identifying HTN.
- Special populations require tailored management approaches.
Findings:
- The Joint National Committee guidelines offer a framework for HTN management.
- Medication selection should consider individual patient factors.
- Evidence-based guidelines aid in optimizing HTN treatment.
Implications:
- Improved HTN management can enhance cancer patient care.
- Adherence to guidelines can lead to better treatment tolerability.
- Further research may refine HTN treatment strategies in oncology.